Nada Elbuluk, MD

Professor of Clinical Dermatology

Culture and Engagement Champion

Image of Nada Elbuluk, MD
Is this your profile? Click to edit

Overview

Dr. Nada Elbuluk is a board-certified dermatologist and Assistant Professor at the USC Keck School of Medicine, Department of Dermatology. She is honored to be a dermatologist at USC and to be able to serve the diverse population of Los Angeles. She is the founder and director of the USC Skin of Color Center and Pigmentary Disorders Clinic. She also serves as the Director of the Dermatology Diversity and Inclusion Program.

Dr. Elbuluk’s clinical and research interests include general medical and cosmetic dermatology,
ethnic skin conditions, and pigmentary disorders including vitiligo, melasma, and postinflammatory pigmentation. She performs a variety of procedures including chemical peels, microneedling, lasers, and botox and has expertise in safely performing these procedures in all skin types.

Dr. Elbuluk received her bachelor’s degree in Psychology from Princeton University where she also minored in Gender Studies and African American Studies. She completed her medical degree at the University of Michigan where she graduated with a Distinction in Research. While there, she received a National Institute of Health award that allowed her to also obtain a Master of Science in Clinical Research from the University of Michigan School of Public Health. She completed her dermatology residency at Johns Hopkins Hospital. Afterwards, she was a fellow and clinical instructor in the Dermatology Department at The University of Pennsylvania. She then spent four years as an Assistant Professor at New York University’s School of Medicine, where she was the founder and director of the pigmentary disorder clinic and served as the Diversity Ambassador for the Department.

Dr. Elbuluk feels strongly about providing her patients with the highest quality of individualized and compassionate care. She also is passionate about teaching and advancing the field of dermatology through research on pigmentary disorders and ethnic skin conditions. She has received several grants to support her research, which has been published in numerous academic journals. She has lectured both national and internationally on her areas of expertise. She also serves as a media expert for the American Academy of Dermatology and has been interviewed by numerous media outlets including the Washington Post, Health, Women’s Health, Essence, Prevention, Allure, Reader’s Digest, the Huffington Post, SELF, and NBC.com.

Dr. Elbuluk is a Diplomate of the American Academy of Dermatology and holds professional memberships with the American Academy of Dermatology, the Women’s Dermatologic Society, the American Society for Dermatologic Surgery, and the Skin of Color Society.

Education and Training

  • Princeton University, Princeton, NJ — BA
  • University of Michigan, Ann Arbor, MI — MSc — Clinical Research
  • University of Michigan, Ann Arbor, MI — MD — Medicine
  • Johns Hopkins, Baltimore, MD — Dermatology, Residency
  • University of Pennsylvania, Philadelphia, PA — Dermatology, Fellowship

Publications

  • Fundamentals of Hyperpigmentation Disorders: Causes, Concerns, and Treatment Strategies, Particularly in Skin of Color Patients. J Drugs Dermatol. 2026 Oct 01; 25(10):926-933.. View in PubMed
  • Best Practices for Managing Pseudofolliculitis Barbae: An Expert Consensus Delphi Study. JAMA Dermatol. 2026 Sep 23.. View in PubMed
  • Cutaneous Aging in Skin of Color: A Narrative Review. Am J Clin Dermatol. 2026 Aug 21.. View in PubMed
  • Economic burden of immune-mediated and psychiatric comorbidities in patients with newly diagnosed vitiligo. J Manag Care Spec Pharm. 2026 Aug 18; 1.. View in PubMed
  • Mentorship in a changing dermatology landscape: new challenges, opportunities, and implications for women. Int J Womens Dermatol. 2026 Oct; 12(3):e287.. View in PubMed
  • The Association of Race and Ethnicity with Patch Test Results: North American Contact Dermatitis Group Data, 2007-2020. J Am Acad Dermatol. 2026 Jul 30.. View in PubMed
  • Public Interest in Hyperpigmentation: Insights From a Google Trends Analysis. J Drugs Dermatol. 2026 Jul 01; 25(7):629-631.. View in PubMed
  • Clinical Characteristics and Treatment Patterns in Patients With Vitiligo. JAMA Dermatol. 2026 Jul 01; 162(7):720-725.. View in PubMed
  • Back to the future: Re-examining in-person dermatology residency interviews from applicant and program perspectives. Dermatol Online J. 2026 Jun 30; 32(3).. View in PubMed
  • Zasocitinib (TAK-279), a Highly Selective Oral TYK2 Inhibitor, Demonstrates Skin Clearance in Patients with Moderate-to-Severe Plaque Psoriasis: Post Hoc Analyses of a Randomized Phase IIb Trial. Dermatol Ther (Heidelb). 2026 Jun; 16(6):3215-3234.. View in PubMed